SHAW CHRISTINE (VP, Assay Development) sold 0.3% of their position (274.00 shares) of GENMARK DIAGNOSTICS, INC. on the open market
Open‑market sale worth $5.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/8/2021ACC: 0001487371-21-000136
Officer· VP, Assay Development
Since Aug 2020
-274.00
Net shares
Net seller
$5.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
274.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−274.00
Price / share
$18.56
Trade value
$5.09K
% of position
0.3%
3/5/2021
102.47K→102.20K
Total
Net shares
−274.00
Net value
-$5.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/5/2021 | S · Sale | −274.00 | $18.56 | $5.09K | 0.3% | 102.47K | 102.20K |
| Total | −274.00 | -$5.09K | ||||||
Derivative Transactions0
No derivative transactions reported